Open AccessIrreversible Coma, Ergotamine, and Ritonavir
Author(s) -
C. Rey,
M Yebra,
Manuel Borrallo,
Almudena Vega,
António Ramos,
Milagros Montero
Publication year - 2003
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/376636
Subject(s) - medicine , ergotamine , ritonavir , coma (optics) , anesthesia , human immunodeficiency virus (hiv) , migraine , virology , physics , viral load , antiretroviral therapy , optics
We report the first case in the medical literature (to our knowledge) of a patient with human immunodeficiency virus infection who was being treated with ritonavir and developed signs of severe vascular involvement and irreversible coma after the administration of 3 mg of ergotamine tartrate.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom